SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021565
Filing Date
2022-11-03
Accepted
2022-11-03 07:51:03
Documents
49
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q inkt-20220930.htm   iXBRL 10-Q 1640456
2 EX-31.1 inkt-ex31_1.htm EX-31.1 20229
3 EX-31.2 inkt-ex31_2.htm EX-31.2 20193
4 EX-32.1 inkt-ex32_1.htm EX-32.1 14070
  Complete submission text file 0000950170-22-021565.txt   4654249

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inkt-20220930_pre.xml EX-101.PRE 180718
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inkt-20220930_cal.xml EX-101.CAL 26674
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inkt-20220930.xsd EX-101.SCH 27738
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inkt-20220930_def.xml EX-101.DEF 85812
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inkt-20220930_lab.xml EX-101.LAB 263553
43 EXTRACTED XBRL INSTANCE DOCUMENT inkt-20220930_htm.xml XML 623411
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40908 | Film No.: 221356295
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences